Cover Image

PAPERBACK
$15.00



View/Hide Left Panel

Appendix B
Workshop Agenda

STATE-OF-THE-ART METHODS FOR EXPLORING CENTRAL NERVOUS SYSTEM DEVELOPMENTAL AND NEURODEGENERATIVE DISORDERS: A WORKSHOP

Monday, July 12

2010 International Conference on Alzheimer’s Disease

1:00 p.m.

Session Overview

 

WILLIAM POTTER

Cochair Emeritus,

Neuroscience Steering Committee,

FNIH Biomarkers Consortium

Former Vice President, Translational Neuroscience,

Merck & Co., Inc.

 

WILLIAM THIES

Vice President, Medical & Scientific Relations

National Alzheimer’s Association



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 21
Appendix B Workshop Agenda STATE-OF-THE-ART METHODS FOR ExPLORINg CENTRAL NERvOuS SYSTEM DEvELOPMENTAL AND NEuRODEgENERATIvE DISORDERS: A WORKSHOP Monday, July 12 2010 International Conference on Alzheimer’s Disease 1:00 p.m. Session Overview William Potter Cochair Emeritus, Neuroscience Steering Committee, FNIH Biomarkers Consortium Former Vice President, Translational Neuroscience, Merck & Co., Inc. William Thies Vice President, Medical & Scientific Relations National Alzheimer’s Association 

OCR for page 21
 LEVERAGING THE ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE 1:10 p.m. Key Elements of ADNI and Moving Forward: What Lessons Can Be Learned for Moving Forward? The National Institutes of Health Perspective ` Neil Buckholtz Chief, Dementias of Aging Branch Division of Neuroscience National Institute on Aging 1:20 p.m. Key Elements of Japanese ADNI and Moving Forward: What Lessons Can Be Learned for Moving Forward? Ikuhisa Sawada Project Coordinator, Biotechnology and Medical Technology Development Department New Energy and Industrial Technology Development Organization 1:30 p.m. Key Elements of European ADNI and Moving Forward: What Lessons Can Be Learned for Moving Forward? ` Giovanni B. Frisoni Vice Scientific Director, IRCCS Centro San Giovanni di Dio FBF The National Centre for Alzheimer’s and Mental Diseases 1:40 p.m. Key Elements of Australian ADNI and Moving Forward: What Lessons Can Be Learned for Moving Forward? Christopher Rowe Director, Department of Nuclear Medicine and Centre for PET Professorial Fellow, University of Melbourne–Austin Health 1:50 p.m. Key Elements of ADNI and Moving Forward: What Lessons Can Be Learned For Moving Forward? An Industry Perspective Howard Feldman Vice President and Therapeutic Area Head, Global Clinical Research Neuroscience Bristol-Myers Squibb

OCR for page 21
 APPENDIx B 2:00 p.m. Panel Discussion: Moving Forward—Identifying Opportunities and Future Synergies for ADNI 2 Steven Paul, Panel Chair Executive Vice President, Science (Former) Eli Lilly Giovanni B. Frisoni Vice Scientific Director, IRCCS Centro San Giovanni di Dio FBF The National Centre for Alzheimer’s and Mental Diseases Howard Feldman Vice President and Therapeutic Area Head, Global Clinical Research Neuroscience Bristol-Myers Squibb Neil Buckholtz Chief, Dementias of Aging Branch Division of Neuroscience National Institute on Aging William Potter Cochair Emeritus, Neuroscience Steering Committee, FNIH Biomarkers Consortium Former Vice President, Translational Neuroscience, Merck & Co., Inc. Christopher Rowe Director, Department of Nuclear Medicine and Centre for PET Professorial Fellow, University of Melbourne–Austin Health Ikuhisa Sawada Project Coordinator, Biotechnology and Medical Technology Development Department New Energy and Industrial Technology Development Organization

OCR for page 21
 LEVERAGING THE ALZHEIMER’S DISEASE NEUROIMAGING INITIATIVE William Thies Vice President, Medical & Scientific Relations National Alzheimer’s Association 2:40 p.m. Discussion with Attendees Steven Paul, Panel Chair Executive Vice President, Science (Former) Eli Lilly 3:00 p.m. Adjourn